Biomimetic Design Restores Flow and Hemodynamics and Leads to Significant LV Mass Regression: Update From the First-In-Human (FIH) Study With the Novel DurAVR Transcatheter Heart Valve

Original Broadcast: June 7, 2024

Conference: NY Valves 2024